Safety of tenecteplase vs. alteplase in telestroke: a large multistate experience (STAT)
IntroductionPrompt treatment with IV thrombolytics (IVT) in acute ischemic stroke (AIS) patients is critical for improved recovery and survival. Recently, hospital systems have switched to the IVT tenecteplase (TNK) instead of the FDA-approved alteplase (tPA) for treatment. Multiple studies and meta...
Saved in:
Main Authors: | Morgan Figurelle, Sandro Corti, Oleg Collins, Lan Gao, Amanda Avila, Kristie Delfino, Laurie Mayer, Theresa Sevilis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2024.1514915/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk of angioedema and thrombolytic therapy among stroke patients: An analysis of data from the FDA Adverse Event Reporting System database
by: Hunong Xiang, et al.
Published: (2025-01-01) -
Thrombolytic therapy for patients with acute ischemic stroke: systematic review and network meta-analysis of randomized trials
by: Li-Chao-Yue Sun, et al.
Published: (2025-01-01) -
Efficacy of Intravenous Tenecteplase Bridge Thrombectomy for Recurrent Ischemic Stroke Within 3 Months: A Case Report
by: Liu C, et al.
Published: (2025-02-01) -
A method to quantitatively characterize the formation and dissociation of tumor cell clusters using light transmission aggregometry
by: Regina Komal Kottana, et al.
Published: (2025-01-01) -
Comparison of the safety and efficacy of dual antiplatelet therapy versus tenecteplase in patients with minor nondisabling acute ischemic stroke
by: Xinzhao Jiang, et al.
Published: (2025-01-01)